Sarepta Therapeutics (SRPT) announced positive topline three-year functional results from Part 1-treated patients in EMBARK, a Phase 3 study in ambulatory individuals with Duchenne muscular dystrophy who were aged four to seven at time of treatment
Sarepta Therapeutics' announcement of positive three-year functional results from a pivotal Phase 3 study could be a strong bullish signal for the stock, particularly as it pertains to their treatment for Duchenne muscular dystrophy.
Microsoft (MSFT) reportedly set to become the only tenant of a new hyper-scale data centre in Amsterdam
Strategy (MSTR) purchases 2.9k worth of BTC for USD 264.1mln between 20-25th of January
Sarepta Therapeutics (SRPT) announced positive topline three-year functional results from Part 1-treated patients in EMBARK, a Phase 3 study in ambulatory individuals with Duchenne muscular dystrophy who were aged four to seven at time of treatment
Saudi Foreign Minister says UAE decided to leave Yemen and if that's the case, Saudi Arabia will assume responsibility
US BROKER MOVES: NFLX upgraded at Phillip Securities; APP upgraded at Needham
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This likely enhances the company's value proposition and may attract increased investor interest, especially among those focused on biotech innovations and rare diseases. Watch for potential movements in the stock as this news could shift sentiment significantly within the sector.
Related headlines
- Newsquawk Weekly US Earnings Estimates: 14-18th September 2026: LEN the only earning all week1 day ago
- Corning (GLW) files for a USD 2bln common stock offering of up to USD 2.0bln1 day ago
- Burry adds to his positions in Zoetis (ZTS) and Lululemon (LULU); sold entire position in Flutter (FLUT)1 day ago
- Google (GOOGL) just completed its USD 1.5bln-plus deal for AI startup Mechanize, reports Business Insider1 day ago
- Estee Lauder (EL) reportedly advances against Walmart (WMT) over knockoffs, according to Bloomberg Law2 days ago
- Situational Awareness builds relationships with new brokers as it attempts rebound, reports FT; is rebuilding large trading positions in stocks such as AMD (AMD), Intel (INTC), SK Hynix (SHY), Sandisk (SNDK) and Coreweave (CRWV)2 days ago
- FanDuel (FLTR) and other sports betting operators are market making on Kalshi, reports Barrons2 days ago
- Paypal's (PYPL) new chief executive, Enrique Lores, is mapping out his plans for going it alone rather than selling the company for more than USD 50bln, reports WSJ2 days ago
- AMD (AMD) says Anthropic framework includes purchases of up to 2GW of the MI450 capacity and Co. is shifting from individual chips to a full system, full rack provider2 days ago
- Tesla (TSLA) says Semi Truck is coming to Europe2 days ago
- GTCR reportedly in talks to purchase software maker SPS Commerce (SPSC)2 days ago
- US EQUITY OPEN: US indices reverse initial CPI losses2 days ago
- Fox's Gasparino says "Paramount’s (PSKY) CEO has "tricks up his sleeve" to get his Warner (WBD) acquisition cleared in California"2 days ago
- Situational Awareness is reportedly active in the options market, according to CNBC citing sources2 days ago
- Chevron (CVX) CEO says early buffers in the oil market have played out and that the price risk from the Iran war is now higher2 days ago
- Daily US Equity Opening News: ORCL gains on earnings and FY guidance beat; ADBE weighed by slight Q4 revenue miss; SMR downgraded2 days ago
- Kroger (KR) executive says food inflation in Q2 was moderately higher than in Q12 days ago
- US PREMARKET MOVERS: ORCL, ADBE, ACVA, KR, RH, CELH, GME, NVO, SMR2 days ago
- US BROKER MOVES: IP upgraded at BofA; NVO downgraded at Morgan Stanley2 days ago
- Kroger (KR) Q2 2026 (USD): Adj. EPS 1.09 (exp. 1.06), revenue 34.6bln (exp. 34.6bln). Cuts SSS outlook 2 days ago
The whole workspace, free to try.
Try it free